Similar Efficacy and Safety of Basaglar® and Lantus® in Patients with Type 2 Diabetes in Age Groups (< 65 Years, ≥ 65 Years): A Post Hoc Analysis from the ELEMENT-2 Study.

Autor:	Pollom, Robyn K.1 pollom_robyn_kaye@lilly.com, Costigan, Timothy1, Lacaya, Lyndon B.1, Ilag, Liza L.1, Hollander, Priscilla A.2
Zdroj:	Diabetes Therapy. Apr2018, Vol. 9 Issue 2, p827-837. 11p.
Databáze:	Academic Search Ultimate
Externí odkaz:	Zobrazit plný text záznamu